|
The history of AIDS (Acquired Immunodeficiency Syndrome), with timelines, photos, and links to resources on the Internet. Endeavoring to raise public awareness through understanding.
|
|
The History of AIDS: Timeline of the History of HIV/AIDS: 1996 1996 On March 1, FDA granted full approval for Norvir (ritonavir) for use alone or in combination with nucleoside analogue medications in people with advanced HIV disease. Norvir also received accelerated approval for less advanced HIV disease. On March 4, FDA granted full approval for Vitrasert (intravitreal implant with Cytovene (ganciclovir) for the treatment of CMV Retinitis. On March 13, FDA granted accelerated approval for Crixivan (indinavir) for use alone or in combination with nucleoside analogue medications in people with HIV or AIDS. FDA approved the drug in just 42 days after receiving its application for marketing. On March 14, FDA approved the first antigen test kit, Coulter HIV-1 p24 Antigen Assay, to screen blood donors for HIV-1. It has been estimated that HIV-1 antigen screening could prevent approximately 5-10 cases per year or up to 25 percent of current cases of HIV infection transmitted by transfusion. On April 8, FDA granted full approval for DaunoXome (daunorubicin citrate lipsome injection) for first line cytotoxic treatment of advanced, HIV-associated Kaposi's Sarcoma On May 14, FDA approved the first HIV test system that can be used at home and can be purchased over-the-counter (OTC). The Confide HIV Testing System, developed by Direct Access Diagnostics, is comprised of three integrated components: an OTC home blood collection kit, HIV-antibody testing at a certified lab, and a test result center that provides test results, counseling and referral anonymously. On June 3, FDA approved Amplicor HIV-1 Monitor Test, an in vitro nucleic acid amplification test for the quantitation of HIV-1 RNA in human plasma (viral load). The test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis. On June 3, FDA approved the HIV-1 western blot confirmatory test for OraSure's oral collection system. The oral collection system was originally approved in 1994 using an enzyme-linked immunosorbent assay (ELISA)method. On June 12, FDA approved Zithromax (azithromycin) for preventing or delaying the onset of infection with mycobacterium avium complex (MAC). On June 21, FDA granted accelerated approval for Viramune (nevirapine) for use in combination with nucleoside analogues to treat adults with HIV infection who have experienced clinical and/or immunological deterioration. On June, 26, FDA approved Vistide (cidofovir) as an intravenous treatment for AIDS-related CMV retinitis, a potentially severe eye infection that can lead to blindness. On July 17, FDA issued a letter to health care providers regarding approximately 15 case reports of spontaneous bleeding episodes in HIV positive patients with hemophilia who were being treated with HIV protease inhibitors at the time of the event. On August 6, FDA approved the first HIV test which uses urine samples. The urine-based test detects the presence of antibodies to HIV-1 using an enzyme-linked immunosorbent assay (ELISA) method. On August 23, FDA approved Serostim (somatropin rDNA origin for injection) for treatment of AIDS wasting and cachexia. 1995 ...Last ||| Next... 1997 |